BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21477291)

  • 1. Pro- and anti-apoptotic CD95 signaling in T cells.
    Paulsen M; Janssen O
    Cell Commun Signal; 2011 Apr; 9():7. PubMed ID: 21477291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of CD4+ T-cell activation by CD95 co-stimulation.
    Paulsen M; Valentin S; Mathew B; Adam-Klages S; Bertsch U; Lavrik I; Krammer PH; Kabelitz D; Janssen O
    Cell Death Differ; 2011 Apr; 18(4):619-31. PubMed ID: 21052094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
    Fulda S; Strauss G; Meyer E; Debatin KM
    Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD95-activated caspase-1 processing of IL-1beta in TCR-mediated proliferation of HIV-infected CD4(+) T cells.
    Petit F; Corbeil J; Lelièvre JD; Moutouh-de Parseval L; Pinon G; Green DR; Ameisen JC; Estaquier J
    Eur J Immunol; 2001 Dec; 31(12):3513-24. PubMed ID: 11745371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
    Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
    J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling.
    Strauss G; Lindquist JA; Arhel N; Felder E; Karl S; Haas TL; Fulda S; Walczak H; Kirchhoff F; Debatin KM
    J Exp Med; 2009 Jun; 206(6):1379-93. PubMed ID: 19487421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
    Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
    Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
    Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases.
    Le Gallo M; Poissonnier A; Blanco P; Legembre P
    Front Immunol; 2017; 8():1216. PubMed ID: 29021794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonapoptotic functions of Fas/CD95 in the immune response.
    Guégan JP; Legembre P
    FEBS J; 2018 Mar; 285(5):809-827. PubMed ID: 29032605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
    Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
    Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo.
    Aragane Y; Maeda A; Cui CY; Tezuka T; Kaneda Y; Schwarz T
    J Invest Dermatol; 2000 Dec; 115(6):1008-14. PubMed ID: 11121134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
    Li-Weber M; Krammer PH
    Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual role of the CD95 and CD95L signaling pathway in glioblastoma.
    Zhang Y; Jin T; Dou Z; Wei B; Zhang B; Sun C
    Front Immunol; 2022; 13():1029737. PubMed ID: 36505426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Facco M; Siviero M; Galvan S; Piazza F; Perin A; Agostini C; Semenzato G
    Blood; 2000 Jul; 96(2):647-54. PubMed ID: 10887130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
    Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
    Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR.
    Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A
    Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation and CD95: a FAScinating switch.
    Sancho-Martinez I; Martin-Villalba A
    Cell Cycle; 2009 Mar; 8(6):838-42. PubMed ID: 19221505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.